Menu

Vega for Biopharma applications

Explore AAV genome characterization data on the Vega benchtop system

Access dataset     Vega system

HiFi sequencing can take your research to the next level, from discovery across the drug development process

Many applications in the drug discovery and development process benefit from highly accurate long reads. With the Vega benchtop long-read system, users can apply these highly accurate long reads to applications like AAV genome characterization, on- and off-target gene editing assessment, scFv antibody development, mRNA vaccine critical quality attribute measurement, insertion site analysis, plasmid sequencing, and cell line characterization.

white icon for aav gene therapy

Gene therapy

Discover, verify, and improve AAV vector design with full-length, highly accurate AAV.

Learn more

Null

Gene editing

Assess on- and off-target CRISPR-Cas9 gene editing outcomes and conduct insertion site analysis.

Learn more

white targeted sequencing icon

Biologics R&D

Enhance your work on biologics, from plasmid sequencing, cell line verification, mRNA full length sequencing, to directed evolution.

Learn more

Application brief

Vega benchtop HiFi sequencing for biopharma research

On the Vega system, you have access to affordable HiFi long-read sequencing with streamlined end-to-end workflows from sample prep to analysis. New SPRQ-Nx chemistry now enables you to get more sequencing output from less input material. Additionally, support for 21 CFR Part 11 compliance is now enabled on Vega, so you can seamlessly move assays from research to regulated environments like GMP.

Learn more

Target and biomarker identification

Comprehensively analyze your samples to identify and validate novel targets and biomarkers

  • Capture SNPs, indels, and larger structural variants to identify novel targets or biomarkers
  • Identify novel RNA isoforms, fusion transcripts and gene expression patterns
  • Integrate epigenetic information into your results with DNA methylation and chromatin accessibility data
  • Generate more comprehensive multiomic datasets

Cell and gene therapy

Design and evaluate the most promising cell and gene therapies for the next generation of novel disease treatments

  • Discover, design, and evaluate novel AAV vectors
  • Comprehensively analyze virus and construct integration sites
  • Confirm plasmid and cell line identity and integrity
  • Fully characterize CRISPR-Cas9 gene editing outcomes

Biologics development

Highly accurate sequencing can elevate some of the most commonly used approaches in biologics research and development

  • Confirm complete plasmid sequences including its backbone
  • Characterize mRNA vaccines including polyA-tail length
  • Develop novel proteins with desired characteristics
  • Confirm cell line identity and genomic integrity

What can you do with one SMRT Cell?

Application Vega system (1 acquisition)
Whole genome sequencing
Human genome (20x coverage) 1.5
Human methylation profiling (5x) 6
De novo assembly 3
Microbial de novo assembly 384
Targeted panels
PureTarget panels 96
Amplicon sequencing > 1,000
Hybrid capture
20 Mb panel 12
2 Mb panel 72
RNA sequencing
Kinnex single-cell RNA sequencing 1 (up to 10,000 cells)
Kinnex full-length RNA sequencing
5 M reads 8
10 M reads 4
Microbial
Shotgun metagenomic profiling 96 communities
Shotgun metagenomic assembly 12 communities
Kinnex 16S rRNA

All sample throughputs are estimates for either the Vega system with 1 acquisition or the Revio system with both 1 or 4 acquisitions using SPRQ or SPRQ-Nx chemistry. Coverage may vary based on sample quality, library quality, and fragment lengths. Currently available SMRTbell® adapter index plates 96A-96D contain a total of 384 SMRTbell barcoded adapters. Microbial de novo assembly assumes microbes with 2 Gb of total genome size at 40x per sample. Single-cell transcriptomics assumes ≥80 million reads per library on the Revio system and ~50-60 million reads per library on the Vega system. Full-length RNA sequencing assumes a total of 60M reads for Revio SPRQ and 40M reads for Vega, regardless of plexity. Amplicon sequencing assumes a 12-hour movie time for 1–5 kb, 24-hour movie time for 5+ kb, and >50× per sample. PureTarget panel assumes >100× mean per target and Revio throughput assumes automated library prep.

Explore other Vega datasets

HiFi genomes     RNA datasets     Targeted panels

Now you can

The Vega benchtop system makes high-accuracy sequencing affordable and accessible to labs of all sizes, bringing the power of HiFi sequencing within reach.

Learn more

Talk with an expert

If you have a question, need to check the status of an order, or are interested in purchasing an instrument, we're here to help.